Human polymorphonuclear leukocytes (PMNL) metabolize the potent chemotaxin leukotriene B4 (LTB4) by 0)-oxidation to 20-hydroxy-LTB4 and 20-carboxy-LTB4. The ability of unstimulated human PMNL to metabolize exogenous LTB4 was found to be inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa, in a dose-dependent manner. 1-Hydroxyphenazine (1-OHP), a metabolite of pyocyanin, was not inhibitory under identical conditions. The initial enzymic step in the conversion of LTB4 is catalyzed by an NADPH-dependent cytochrome, P-450. Reduction of the phenazine derivatives by NADPH was measured spectrophotometrically. Pyocyanin was reduced by NADPH in vitro in a pH-dependent manner, while 1-OHP was poorly or negligibly reduced under similar conditions. Formation of NADP+ was 20.3 + 1.8 nmol min-' for pyocyanin (10 ,uM) at pH 5.5, compared with 0.6 + 0.2 nmol min-' for 1-OHP (10 ,uM), while at pH 7.5 a value of 2.2 ± 1.3 nmol min-' was obtained for pyocyanin, with no detectable activity for 1-OHP.
This indicates that inhibition of LTB4 w-hydroxylase activity by pyocyanin might be achieved by competition for NADPH. Incorporation of exogenous 5-hydroxyeicosatetraenoic acid by PMNL into lipid pools was not affected by either phenazine derivative. The ability of bacterial pyocyanin to limit the w-oxidation of LTB4 may have important implications for PMNL LTB4 receptor status and chemotaxis in vivo.
Stimulation of human polymorphonuclear leukocytes (PMNL) by natural or artificial stimuli elicits production of leukotriene B4 (LTB4) and 5-hydroxyeicosatetraenoic acid (5-HETE) via the 5-lipoxygenase pathway. These eicosanoids exhibit a number of important biological functions and exert their effects at low concentrations. LTB4 induces human PMNL aggregation, degranulation, adherence to endothelial cell membranes, and chemotaxis, in addition to other functions (3) . The biological activity of LTB4 is regulated in human PMNL by w-hydroxylation to the less active but still chemotactic compound 20-hydroxy-LTB4. The enzyme involved has been shown to be a membrane-bound, NADPH-dependent cytochrome designated P-450LTB. (4, 22) . In microsomes of human origin, subsequent metabolism and inactivation of 20-hydroxy-LTB4 have been demonstrated to occur by further action of P-450LTBO (23) or by action of NAD+-dependent dehydrogenases to yield 20-carboxy-LTB4 (9, 25) . 5-HETE has been reported to be processed by unstimulated PMNL by incorporation into triglyceride and phospholipid (19, 24) , although w-oxidation of 5-HETE has also been described (20) .
Pseudomonas aeruginosa, an opportunistic bacterium which is associated with chronic colonization of the lungs of patients with cystic fibrosis, produces substantial quantities of the phenazine derivative pyocyanin (1-hydroxy-5-methylphenazinium hydroxide inner salt). The effects of this derivative and 1-hydroxyphenazine (1-OHP), a metabolite of pyocyanin, on the biosynthesis of LTB4 and 5-HETE by human PMNL have been described by us previously (16) . We now present observations that indicate that metabolism of LTB4 to its -oxidation products is inhibited by pyocya-* Corresponding author.
nin but not 1-OHP in unstimulated human PMNL, whereas 5-HETE metabolism remains unaffected.
MATERIALS AND METHODS
Preparation of PMNL. Normal PMNL were obtained from the blood of healthy volunteers. Briefly, PMNL were prepared from 30 ml of anticoagulated venous blood by centrifugation at 250 x g for 45 min through 20 ml of Mono-Poly Resolving medium (Flow Laboratories, Sydney, Australia). The PMNL layer was removed and washed with calciumand magnesium-free Hanks balanced salt solution. Contaminating erythrocytes were removed by hypotonic lysis. PMNL (95% purity or greater) were washed, suspended in complete Hanks balanced salt solution containing calcium and magnesium, and used at a concentration of 5 x 106 cells per ml for all experiments. [5, 6, 8, 9, 11, 12, 14, 15 1-OHP was prepared by a modification of the method of Armstrong et al. (1) . Pyocyanin was added to a 1% solution of NaOH and allowed to stand in the dark for 3 h. The solution was acidified with 1 M HCl until a yellow solution was obtained. The crude 1-OHP was extracted twice into 1 volume of chloroform, and the pooled extracts were evaporated to dryness under vacuum.
Final purification of pyocyanin and 1-OHP was performed by thin-layer chromatography on silica gel G with chloroform-methanol (9:1, vol/vol). The identity of each derivative was confirmed by comparison of its UV spectrum and extinction coefficient with established values (27) . Before use, the purity of each derivative was checked by thin-layer chromatography as described above. Extraction and separation of metabolites. All reactions were terminated by addition of 1 volume of methanol. After extraction by the method of Bligh and Dyer (2), arachidonic acid metabolites were suspended in chloroform-methanol (9:1, vol/vol) and separated by thin-layer chromatography on silica gel G by using a solvent system consisting of chloroform-methanol-acetic acid-water (90:8:1:0.8, vol/vol/vol/vol) (18) thin-layer chromatography by using the system described above. The identity of each unlabelled compound was further checked by elution from the appropriate gel band with methanol and determination of its UV spectrum. In each case, the conjugated triene structure with absorption maxima characteristic of LTB4 or its derivatives was found.
Spectrophotometric assays. The absorption spectrum of 0.1 mM NADPH in 0.1 M Tris-HCl buffer was determined alone and in the presence of 10 and distribution into lipid classes of labelled LTB4 and 5-HETE by untreated PMNL and compared the results with those obtained with pyocyanin-or 1-OHP-treated cells. As shown in Fig. 1A , LTB4 was converted predominantly to o-oxidation products. We found that 5% or less of the label was incorporated into neutral lipid and phospholipid at any time point between 0 and 60 min, in agreement with the work of others (21) (data not shown). Under identical conditions, 5-HETE was metabolized relatively rapidly. A time of 18 min was required to reduce the initial amount of LTB4 by 50%, whereas a similar reduction in 5-HETE required only 2.5 min. 5-HETE was incorporated predominantly into neutral lipid, with negligible incorporation into phospholipid or production of b-oxidation products. Thin-layer chromatography of the neutral lipid fractions revealed that 5-HETE was incorporated into triglyceride (Fig. 1B) . While this was in agreement with previously published results, the low incorporation into phospholipid was contrary to previous reports (20, 24) .
Treatment with phenazines. Pretreatment with increasing concentrations of pyocyanin (12.5 to 200 pM) resulted in a dose-dependent decrease in the formation of w-oxidation products of LTB4 (Fig. 2) . The dose of pyocyanin required to achieve 50% inhibition was calculated to be 87.5 p,M. The major product recovered after incubation with pyocyanin comigrated with authentic LTB4 on thin-layer chromatogra- phy and not with o-oxidation metabolites. Inhibition of LTB4 metabolism was not observed in PMNL treated with 1-OHP (Fig. 3) .
[3H]5-HETE metabolism was not altered by treatment with either pyocyanin or 1-OHP (data not shown). Under the conditions employed for these studies, no w-oxidation of 5-HETE was observed.
Spectrophotometric studies. To determine the mechanism responsible for the differential inhibition observed with the two phenazine derivatives, we measured the rates of reduction of pyocyanin and 1-OHP by NADPH spectrophotometrically. We found a significant difference in the rate of reaction between the two derivatives. Pyocyanin (10 ,uM) was reduced at all pH values at a significantly greater rate than 1-OHP and in a pH-dependent manner (Table 1) LTB4 and 5-HETE from stimulated human PMNL at concentrations of 50 jxM or less. In addition, we observed a decline in the production of LTB4 w-oxidation products, presumably owing to a reduction in the amount of the LTB4 substrate available (16) . In this study, we investigated the effects of phenazine derivatives on the metabolism of exogenous [3H]LTB4 and [3H]5-HETE by PMNL.
Exposure of unstimulated PMNL to clinically relevant concentrations (28) of either pyocyanin or 1-OHP resulted in dose-dependent inhibition of LTB4 metabolism only in the case of pyocyanin, while 1-OHP was without effect. As the dominant product recovered after incubation of PMNL with exogenous LTB4 and pyocyanin was the parent compound and not intermediates of the w-oxidation pathway, we conclude that the initial step, conversion of LTB4 to 20-OH-LTB4, is the site of action of pyocyanin. In investigating the reason for the discrepancy between the actions of pyocyanin and 1-OHP, we examined their abilities to oxidize NADPH at various pH values. PMNL degranulation, a process promoted by LTB4 (3), is thought to induce localized intracellular pH changes in PMNL. Although precise local pH values are not known, a pH of 5.0 is considered possible (11) . P-450LTB. has been shown to be a membrane-bound, NADPH-dependent system (22) . Substantial depletion of intracellular NADPH by pyocyanin has been reported to occur in human PMNL (15) , and we have established in the present study that pyocyanin can initiate NADPH oxidation in a pH-dependent manner, whereas 1-OHP does so only poorly. We conclude that inhibition of P-450LThB. by pyocy- anin is achieved by causing the substrate, NADPH, to become limiting and propose the mechanism illustrated in Fig. 4 to account for our observations. That 1-OHP is ineffective as an inhibitor of LTB4 metabolism is most likely due to its poor ability to oxidize NADPH.
The interaction of reduced pyocyanin with molecular oxygen can generate the oxygen free radical superoxide (10) . It has been proposed that free radicals generated by phenazine derivatives can inactivate dehydrogenase systems in vitro (5), and we have found that pyocyanin and 1-OHP, using NADH as an electron donor, alter lactate dehydrogenase activity (17) . However, the possible inactivation of P-45OLTB. by this mechanism is unlikely, as it has been previously demonstrated in unstimulated PMNL that pyocyanin concentrations of up to 200 ,uM did not lead to formation of superoxide but did cause significant depletion of NADPH (15) .
Metabolism of 5-HETE by PMNL treated with pyocyanin or 1-OHP was not affected, indicating that the acyltransferase(s) involved in esterifying 5-HETE into neutral lipid is not phenazine sensitive. Although c-oxidation of 5-HETE has been reported to occur at high substrate concentrations (20) , under the conditions employed in this study we were unable to detect w-oxidized metabolites of 5-HETE and, hence, could not evaluate the influence of phenazine derivatives on this activity.
While LTB4 is not the only chemotaxin present at infection sites, it is a significant endogenous chemotaxin when compared on a mole-for-mole basis with other substances (7) . It has been demonstrated that LTB4 is the major PMNL chemotaxin produced by human alveolar macrophages (14) . Possession by P. aeruginosa of a mechanism for preventing inactivation of LTB4 by human PMNL appears to be inconsistent with long-term survival of the organism, since increased chemotaxis of PMNL and macrophages in response to LTB4 should result in increased phagocytosis and bacterial killing at the infection site. However, it has been demonstrated that prior exposure of human PMNL to LTB4 leads to loss of their chemotactic responsiveness with respect to LTB4 (6) . This loss has been attributed to down regulation of high-affinity LTB4 receptors on the cell surface (8, 26) . As PMNL are the only cells known to inactivate LTB4 effectively by c-oxidation (13), the inability of PMNL exposed to pyocyanin to inactivate this compound may result in down regulation of PMNL LTB4 receptors in vivo and may reduce LTB4-mediated chemotaxis. Thus, an advantage may be conferred upon the pathogen for survival within the host. PMNL infiltration into infection sites in response to other chemotaxins could still occur, and these substances may then become more important than LTB4 as the principal chemotaxins.
We conclude that pyocyanin appears to play an important role in altering the synthesis and subsequent metabolism of LTB4 by human PMNL. As LTB4 is considered to be a major mediator of inflammation, we conclude that bacterial pyocyanin may have a significant role as a virulence factor in this process. Thus, pyocyanin may contribute to the persistence of P. aeruginosa in chronic disease, particularly in lung infections such as cystic fibrosis and bronchiectasis. 
